Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Echocardiography (Mount Kisco, N.Y.)|February 25, 2021
Percutaneous puncture of an aorto-bifemoral bypass graft and successful closure with MANTA® device in transfemoral TAVRMartin Geyer, Alexander R Tamm, Martin Oberhoffer, et al.
Echocardiography (Mount Kisco, N.Y.)|October 3, 2023
"Piggyback Pigtails": Simplifying secondary transradial access for TAVRMajid Ahoopai, Martin Geyer, Alexander R Tamm, et al.
Medical Devices (Auckland, N.Z.)|March 23, 2018
A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleedingDavid Glineur, Marc Hendrikx, Dainis Krievins, et al.
The Annals of Thoracic Surgery|August 4, 2015
Corrective Operation in an Intramyocardial Dissecting Hemorrhage After Subacute Anterior Myocardial InfarctionEdda Bahlmann, Martin Oberhoffer, Felix Kreidel, et al.
Surgical Technology International|November 30, 2014
European Initial Hands-On Experience with HEMOPATCH, a Novel Sealing Hemostatic Patch: Application in General, Gastrointestinal, Biliopancreatic, Cardiac, and Urologic SurgeryAbe Fingerhut, Selman Uranues, Giuseppe Maria Ettorre, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 24, 2025
Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trialMelanie Arnreiter, Moritz von Scheidt, Johannes M Albes, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
American Heart Journal|September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trialAntoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
Pageof 3